(Q43257610)

English

Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study

scientific article published in November 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

13

object named as

Emilio Perucca

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

John M Wild

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Catherine Chiron

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Hyosook Ahn

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Michel Baulac

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Joseph Bursztyn

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Enrico Gandolfo

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ivan Goldberg

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Francisco Javier Goñi

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Florence Mercier

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Jean-Philippe Nordmann

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Avinoam B Safran

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ulrich Schiefer

12

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

965-982

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Severe persistent visual field constriction associated with vigabatrin

1 reference

https://api.crossref.org/works/10.2165%2F11317650-000000000-00000

21 January 2018

No reversion in vigabatrin-associated visual field defects

1 reference

https://api.crossref.org/works/10.2165%2F11317650-000000000-00000

21 January 2018

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

1 reference

https://api.crossref.org/works/10.2165%2F11317650-000000000-00000

21 January 2018

Pharmacology of Vigabatrin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual field constriction and electrophysiological changes associated with vigabatrin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual function in infants with West syndrome: correlation with EEG patterns

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of a unique visual field defect attributed to vigabatrin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect on vision of associated treatments in patients taking vigabatrin: carbamazepine versus valproate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The legacy of vigabatrin in a regional epilepsy clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced visual function associated with infantile spasms in children on vigabatrin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasticity in the adult visual cortex: implications for the diagnosis of visual field defects and visual rehabilitation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual field loss associated with vigabatrin: quantification and relation to dosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin visual toxicity: evolution and dose dependence

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual field defects with vigabatrin: epidemiology and therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual field constriction in 91 Finnish children treated with vigabatrin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual field defects due to antiepileptic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology and clinical pharmacology of vigabatrin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is visual field constriction in epilepsy patients treated with vigabatrin reversible?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin and visual field defects in pediatric epilepsy patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment with vigabatrin - 10 years of clinical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentric contraction of the visual field in patients with temporal lobe epilepsy and its association with the use of vigabatrin medication

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the electroretinogram resulting from discontinuation of vigabatrin in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing the indication of vigabatrin in children with refractory epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled study of vigabatrin and visual abnormalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin-associated visual field constriction in a longitudinal series. Reversibility suggested after drug withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin: longterm follow-up of electrophysiology and visual field examinations

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between difficulty in performing daily activities and clinical measures of visual function in patients with retinitis pigmentosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vigabatrin and epilepsy: lessons learned

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electro-ophthalmological recovery after withdrawal from vigabatrin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845417

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11317650-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43257610&oldid=2205913388"